Guolin Chai

564 total citations
9 papers, 464 citations indexed

About

Guolin Chai is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Guolin Chai has authored 9 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Neurology and 2 papers in Oncology. Recurrent topics in Guolin Chai's work include Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Bone Tumor Diagnosis and Treatments (2 papers). Guolin Chai is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers) and Bone Tumor Diagnosis and Treatments (2 papers). Guolin Chai collaborates with scholars based in China, United States and Canada. Guolin Chai's co-authors include Wei‐Guo Zhu, Lipeng Wu, Yu Yu, Ying Zhao, Wen Zhou, Haiying Wang, Shaoli Lu, Gregory A. Otterson, Yingqi Chen and Jia Sun and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Guolin Chai

8 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guolin Chai China 6 377 110 81 39 36 9 464
Ami Albihn Sweden 8 323 0.9× 127 1.2× 83 1.0× 67 1.7× 32 0.9× 8 426
Rahul Sreekumar United Kingdom 7 199 0.5× 110 1.0× 123 1.5× 52 1.3× 29 0.8× 12 317
Lucia García-Gutiérrez Spain 9 305 0.8× 132 1.2× 62 0.8× 8 0.2× 31 0.9× 15 417
Namrata Bhatnagar United States 5 270 0.7× 94 0.9× 187 2.3× 79 2.0× 17 0.5× 6 397
Rintaro Okoshi Japan 8 348 0.9× 201 1.8× 113 1.4× 17 0.4× 18 0.5× 10 443
Chandrika Jeyamohan United States 6 224 0.6× 89 0.8× 145 1.8× 10 0.3× 26 0.7× 9 358
Hui-Kuan Lin United States 6 310 0.8× 115 1.0× 68 0.8× 6 0.2× 26 0.7× 8 384
Atrayee Bhattacharya United States 13 310 0.8× 159 1.4× 98 1.2× 17 0.4× 23 0.6× 33 444
Lin‐wen Wu China 12 225 0.6× 88 0.8× 82 1.0× 18 0.5× 24 0.7× 18 381
Yitao Wang China 10 230 0.6× 89 0.8× 95 1.2× 14 0.4× 22 0.6× 11 330

Countries citing papers authored by Guolin Chai

Since Specialization
Citations

This map shows the geographic impact of Guolin Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guolin Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guolin Chai more than expected).

Fields of papers citing papers by Guolin Chai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guolin Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guolin Chai. The network helps show where Guolin Chai may publish in the future.

Co-authorship network of co-authors of Guolin Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Guolin Chai. A scholar is included among the top collaborators of Guolin Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guolin Chai. Guolin Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sun, Bolu, Yuqiong Wu, Huajie Li, et al.. (2025). A neuraminidase-based electrochemical biosensor for high-throughput screening of antiviral compounds in traditional Chinese medicine. Microchimica Acta. 192(6). 378–378.
2.
Wang, Yanping, et al.. (2024). Neuroprotective effects of total phenolics from Hemerocallis citrina Baroni leaves through the PI3K/AKT pathway. Frontiers in Pharmacology. 15. 1370619–1370619. 4 indexed citations
4.
Xu, Ning, et al.. (2013). Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1. Chinese Medical Journal. 126(1). 101–107. 4 indexed citations
5.
Liu, Ning, Lijun Zhao, Xiaoping Li, et al.. (2012). Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.. PubMed. 125(18). 3273–8. 10 indexed citations
6.
Chai, Guolin, Ning Liu, Junrong Ma, et al.. (2010). MicroRNA‐10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Science. 101(9). 1997–2004. 82 indexed citations
7.
Chai, Guolin, Lian Li, Wen Zhou, et al.. (2008). HDAC Inhibitors Act with 5-aza-2′-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells. PLoS ONE. 3(6). e2445–e2445. 59 indexed citations
8.
Wang, Haiying, Ying Zhao, Lian Li, et al.. (2007). An ATM- and Rad3-related (ATR) Signaling Pathway and a Phosphorylation-Acetylation Cascade Are Involved in Activation of p53/p21Waf1/Cip1 in Response to 5-Aza-2′-deoxycytidine Treatment. Journal of Biological Chemistry. 283(5). 2564–2574. 50 indexed citations
9.
Zhao, Ying, Shaoli Lu, Lipeng Wu, et al.. (2006). Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21Waf1/Cip1. Molecular and Cellular Biology. 26(7). 2782–2790. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026